Kevin St. P. McNaught, Ph.D., is vice president for medical and scientific programs at the Tourette Syndrome Association, the only national voluntary nonprofit membership organization supporting scientific and clinical research for this childhood onset disorder. Dr. McNaught guides the development, implementation and management of the association’s medical, scientific and therapeutics research and forges collaborations with the pharmaceutical industry. In addition, he oversees the association’s external advisory boards and serves as liaison with government agencies addressing childhood brain disorders. Dr. McNaught’s prior position was as an assistant professor in the Department of Neurology in New York City’s Mount Sinai School of Medicine, where he conducted research on Parkinson’s disease and related neurodegenerative disorders and examined novel therapeutic approaches. He previously worked at the Center for Neuroregeneration Research at Harvard Medical School/McLean Hospital in Belmont, Mass., and in the Department of Biochemistry at the University of Cambridge, U.K. Dr. McNaught earned his Ph.D. in pharmacology from King’s College London (University of London).
Last Modified January 23, 2012